Gallacher Capital Management LLC Buys New Stake in The Clorox Company $CLX

Gallacher Capital Management LLC acquired a new position in shares of The Clorox Company (NYSE:CLX) in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 4,848 shares of the company’s stock, valued at approximately $598,000.

A number of other hedge funds have also made changes to their positions in the business. Total Investment Management Inc. purchased a new position in Clorox in the second quarter valued at approximately $25,000. True Wealth Design LLC boosted its holdings in shares of Clorox by 1,020.0% in the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after buying an additional 204 shares in the last quarter. NewSquare Capital LLC boosted its holdings in shares of Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after buying an additional 193 shares in the last quarter. Root Financial Partners LLC purchased a new position in shares of Clorox in the 3rd quarter valued at $29,000. Finally, Darwin Wealth Management LLC acquired a new stake in Clorox during the 2nd quarter worth $29,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction dated Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the purchase, the director directly owned 13,000 shares in the company, valued at $1,353,690. This trade represents a 44.44% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX opened at $117.68 on Thursday. The Clorox Company has a 52 week low of $96.66 and a 52 week high of $159.04. The company has a 50-day moving average price of $105.39 and a 200 day moving average price of $113.99. The company has a market cap of $14.35 billion, a P/E ratio of 19.23, a PEG ratio of 0.57 and a beta of 0.59. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 299.67% and a net margin of 11.17%.The business’s quarterly revenue was down .8% on a year-over-year basis. During the same period last year, the company posted $1.55 earnings per share. Research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.2%. The ex-dividend date is Wednesday, January 28th. Clorox’s payout ratio is presently 77.86%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Morgan Stanley decreased their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research report on Friday, January 9th. JPMorgan Chase & Co. lifted their price target on Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research report on Wednesday. The Goldman Sachs Group reduced their price objective on Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a research note on Wednesday, January 7th. Finally, Jefferies Financial Group lowered their target price on shares of Clorox from $152.00 to $151.00 and set a “buy” rating on the stock in a research report on Wednesday. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus target price of $117.00.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Revenue slightly beat consensus — Q2 revenue came in at about $1.67B, a small beat versus Street estimates, which helps offset some concerns about profitability. Q2 Results Press Release
• Positive Sentiment: Some analysts still see significant upside — Jefferies retains a “buy” rating with a $151 target, signaling that at least part of Wall Street believes longer-term upside remains. Jefferies PT Article
• Neutral Sentiment: Management will present at the CAGNY conference on Feb. 19 — provides an opportunity for management to address questions about margin recovery, inventory and integration progress (potentially market-moving if new color is provided). CAGNY Presentation Notice
• Neutral Sentiment: Mixed small analyst adjustments — JPMorgan nudged its target slightly higher to $117 (neutral), signaling little change in near-term consensus. JPMorgan PT Article
• Negative Sentiment: EPS missed expectations and declined year‑over‑year — adjusted EPS of $1.39 missed consensus (~$1.43) and is down from a year ago, which pressured sentiment. Reuters Earnings Coverage
• Negative Sentiment: Margin headwinds persist — management cited higher costs, ERP/integration pressures and an inventory reset that could squeeze near‑term profits; several outlets flagged margin pressure and a profit squeeze outlook for 2026. Benzinga Profit Squeeze
• Negative Sentiment: Analyst downgrades/price‑target cuts on balance — Evercore cut its PT to $115 (underperform) and Deutsche Bank trimmed its PT to $112 (hold), adding downside risk near current levels. Evercore PT Article Deutsche Bank PT Article

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.